Dealing with an insufficient future liver remnant: Portal vein embolization and two‐stage hepatectomy

Colorectal liver metastases (CLM) are not always resectable at the time of diagnosis. An insufficient future liver remnant is a factor excluding patients from curative intent resection. To deal with this issue, two‐stage hepatectomy was introduced approximately 20 years ago. It is a sequential treat...

Full description

Saved in:
Bibliographic Details
Published in:Journal of surgical oncology 2019-04, Vol.119 (5), p.594-603
Main Authors: Kawaguchi, Yoshikuni, Lillemoe, Heather A., Vauthey, Jean‐Nicolas
Format: Article
Language:English
Subjects:
Antineoplastic Agents - adverse effects
Cancer surgery
Chemical and Drug Induced Liver Injury - etiology
colorectal liver metastasis
Colorectal Neoplasms - pathology
Embolization
Embolization, Therapeutic - methods
future liver remnant
Hepatectomy - methods
Humans
Liver
Liver Neoplasms - secondary
Liver Neoplasms - therapy
Metastasis
Portal Vein
portal vein embolization
two‐stage hepatectomy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3880-6bf5d1244186ecd01a5cef09a8aed7e6e8f94c28aefd2eb88df617d09ce09e243
cites cdi_FETCH-LOGICAL-c3880-6bf5d1244186ecd01a5cef09a8aed7e6e8f94c28aefd2eb88df617d09ce09e243
container_end_page 603
container_issue 5
container_start_page 594
container_title Journal of surgical oncology
container_volume 119
creator Kawaguchi, Yoshikuni
Lillemoe, Heather A.
Vauthey, Jean‐Nicolas
description Colorectal liver metastases (CLM) are not always resectable at the time of diagnosis. An insufficient future liver remnant is a factor excluding patients from curative intent resection. To deal with this issue, two‐stage hepatectomy was introduced approximately 20 years ago. It is a sequential treatment strategy for bilateral CLM, which consists of preoperative chemotherapy, portal vein embolization, and planned first and second liver resections. This study reviews current evidence supporting use of two‐stage hepatectomy.
doi_str_mv 10.1002/jso.25430
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2193305115</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2193305115</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3880-6bf5d1244186ecd01a5cef09a8aed7e6e8f94c28aefd2eb88df617d09ce09e243</originalsourceid><addsrcrecordid>eNp1kMtKAzEUQIMoWh8Lf0ACrlyM3mQeTdxJfSMoqOshnbmpKTNJTTKWuvIT_Ea_xNGqO1fhknPPhUPILoNDBsCPpsEd8jxLYYUMGMgikSDFKhn0fzzJhhI2yGYIUwCQssjWyUYKguecpwMyOUXVGDuhcxOfqLLU2NBpbSqDNlLdxc4jbcwLeuqxtcrGY3rnfFQNfUFjKbZj15hXFY2z_XpN49x9vL2HqCZIn3CmIlbRtYttsqZVE3Dn590ij-dnD6PL5Ob24mp0cpNUqRCQFGOd14xnGRMFVjUwlVeoQSqhsB5igULLrOL9pGuOYyFqXbBhDbJCkMizdIvsL70z7547DLGcus7b_mTJmUxTyBnLe-pgSVXeheBRlzNvWuUXJYPyK2nZJy2_k_bs3o-xG7dY_5G_DXvgaAnMTYOL_03l9f3tUvkJxNqDSQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2193305115</pqid></control><display><type>article</type><title>Dealing with an insufficient future liver remnant: Portal vein embolization and two‐stage hepatectomy</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Kawaguchi, Yoshikuni ; Lillemoe, Heather A. ; Vauthey, Jean‐Nicolas</creator><creatorcontrib>Kawaguchi, Yoshikuni ; Lillemoe, Heather A. ; Vauthey, Jean‐Nicolas</creatorcontrib><description>Colorectal liver metastases (CLM) are not always resectable at the time of diagnosis. An insufficient future liver remnant is a factor excluding patients from curative intent resection. To deal with this issue, two‐stage hepatectomy was introduced approximately 20 years ago. It is a sequential treatment strategy for bilateral CLM, which consists of preoperative chemotherapy, portal vein embolization, and planned first and second liver resections. This study reviews current evidence supporting use of two‐stage hepatectomy.</description><identifier>ISSN: 0022-4790</identifier><identifier>EISSN: 1096-9098</identifier><identifier>DOI: 10.1002/jso.25430</identifier><identifier>PMID: 30825223</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Antineoplastic Agents - adverse effects ; Cancer surgery ; Chemical and Drug Induced Liver Injury - etiology ; colorectal liver metastasis ; Colorectal Neoplasms - pathology ; Embolization ; Embolization, Therapeutic - methods ; future liver remnant ; Hepatectomy - methods ; Humans ; Liver ; Liver Neoplasms - secondary ; Liver Neoplasms - therapy ; Metastasis ; Portal Vein ; portal vein embolization ; two‐stage hepatectomy</subject><ispartof>Journal of surgical oncology, 2019-04, Vol.119 (5), p.594-603</ispartof><rights>2019 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3880-6bf5d1244186ecd01a5cef09a8aed7e6e8f94c28aefd2eb88df617d09ce09e243</citedby><cites>FETCH-LOGICAL-c3880-6bf5d1244186ecd01a5cef09a8aed7e6e8f94c28aefd2eb88df617d09ce09e243</cites><orcidid>0000-0003-2986-3224 ; 0000-0003-4921-5427</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30825223$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kawaguchi, Yoshikuni</creatorcontrib><creatorcontrib>Lillemoe, Heather A.</creatorcontrib><creatorcontrib>Vauthey, Jean‐Nicolas</creatorcontrib><title>Dealing with an insufficient future liver remnant: Portal vein embolization and two‐stage hepatectomy</title><title>Journal of surgical oncology</title><addtitle>J Surg Oncol</addtitle><description>Colorectal liver metastases (CLM) are not always resectable at the time of diagnosis. An insufficient future liver remnant is a factor excluding patients from curative intent resection. To deal with this issue, two‐stage hepatectomy was introduced approximately 20 years ago. It is a sequential treatment strategy for bilateral CLM, which consists of preoperative chemotherapy, portal vein embolization, and planned first and second liver resections. This study reviews current evidence supporting use of two‐stage hepatectomy.</description><subject>Antineoplastic Agents - adverse effects</subject><subject>Cancer surgery</subject><subject>Chemical and Drug Induced Liver Injury - etiology</subject><subject>colorectal liver metastasis</subject><subject>Colorectal Neoplasms - pathology</subject><subject>Embolization</subject><subject>Embolization, Therapeutic - methods</subject><subject>future liver remnant</subject><subject>Hepatectomy - methods</subject><subject>Humans</subject><subject>Liver</subject><subject>Liver Neoplasms - secondary</subject><subject>Liver Neoplasms - therapy</subject><subject>Metastasis</subject><subject>Portal Vein</subject><subject>portal vein embolization</subject><subject>two‐stage hepatectomy</subject><issn>0022-4790</issn><issn>1096-9098</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp1kMtKAzEUQIMoWh8Lf0ACrlyM3mQeTdxJfSMoqOshnbmpKTNJTTKWuvIT_Ea_xNGqO1fhknPPhUPILoNDBsCPpsEd8jxLYYUMGMgikSDFKhn0fzzJhhI2yGYIUwCQssjWyUYKguecpwMyOUXVGDuhcxOfqLLU2NBpbSqDNlLdxc4jbcwLeuqxtcrGY3rnfFQNfUFjKbZj15hXFY2z_XpN49x9vL2HqCZIn3CmIlbRtYttsqZVE3Dn590ij-dnD6PL5Ob24mp0cpNUqRCQFGOd14xnGRMFVjUwlVeoQSqhsB5igULLrOL9pGuOYyFqXbBhDbJCkMizdIvsL70z7547DLGcus7b_mTJmUxTyBnLe-pgSVXeheBRlzNvWuUXJYPyK2nZJy2_k_bs3o-xG7dY_5G_DXvgaAnMTYOL_03l9f3tUvkJxNqDSQ</recordid><startdate>20190401</startdate><enddate>20190401</enddate><creator>Kawaguchi, Yoshikuni</creator><creator>Lillemoe, Heather A.</creator><creator>Vauthey, Jean‐Nicolas</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><orcidid>https://orcid.org/0000-0003-2986-3224</orcidid><orcidid>https://orcid.org/0000-0003-4921-5427</orcidid></search><sort><creationdate>20190401</creationdate><title>Dealing with an insufficient future liver remnant: Portal vein embolization and two‐stage hepatectomy</title><author>Kawaguchi, Yoshikuni ; Lillemoe, Heather A. ; Vauthey, Jean‐Nicolas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3880-6bf5d1244186ecd01a5cef09a8aed7e6e8f94c28aefd2eb88df617d09ce09e243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Antineoplastic Agents - adverse effects</topic><topic>Cancer surgery</topic><topic>Chemical and Drug Induced Liver Injury - etiology</topic><topic>colorectal liver metastasis</topic><topic>Colorectal Neoplasms - pathology</topic><topic>Embolization</topic><topic>Embolization, Therapeutic - methods</topic><topic>future liver remnant</topic><topic>Hepatectomy - methods</topic><topic>Humans</topic><topic>Liver</topic><topic>Liver Neoplasms - secondary</topic><topic>Liver Neoplasms - therapy</topic><topic>Metastasis</topic><topic>Portal Vein</topic><topic>portal vein embolization</topic><topic>two‐stage hepatectomy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kawaguchi, Yoshikuni</creatorcontrib><creatorcontrib>Lillemoe, Heather A.</creatorcontrib><creatorcontrib>Vauthey, Jean‐Nicolas</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><jtitle>Journal of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kawaguchi, Yoshikuni</au><au>Lillemoe, Heather A.</au><au>Vauthey, Jean‐Nicolas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dealing with an insufficient future liver remnant: Portal vein embolization and two‐stage hepatectomy</atitle><jtitle>Journal of surgical oncology</jtitle><addtitle>J Surg Oncol</addtitle><date>2019-04-01</date><risdate>2019</risdate><volume>119</volume><issue>5</issue><spage>594</spage><epage>603</epage><pages>594-603</pages><issn>0022-4790</issn><eissn>1096-9098</eissn><abstract>Colorectal liver metastases (CLM) are not always resectable at the time of diagnosis. An insufficient future liver remnant is a factor excluding patients from curative intent resection. To deal with this issue, two‐stage hepatectomy was introduced approximately 20 years ago. It is a sequential treatment strategy for bilateral CLM, which consists of preoperative chemotherapy, portal vein embolization, and planned first and second liver resections. This study reviews current evidence supporting use of two‐stage hepatectomy.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>30825223</pmid><doi>10.1002/jso.25430</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0003-2986-3224</orcidid><orcidid>https://orcid.org/0000-0003-4921-5427</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-4790
ispartof Journal of surgical oncology, 2019-04, Vol.119 (5), p.594-603
issn 0022-4790
1096-9098
language eng
recordid cdi_proquest_journals_2193305115
source Wiley-Blackwell Read & Publish Collection
subjects Antineoplastic Agents - adverse effects
Cancer surgery
Chemical and Drug Induced Liver Injury - etiology
colorectal liver metastasis
Colorectal Neoplasms - pathology
Embolization
Embolization, Therapeutic - methods
future liver remnant
Hepatectomy - methods
Humans
Liver
Liver Neoplasms - secondary
Liver Neoplasms - therapy
Metastasis
Portal Vein
portal vein embolization
two‐stage hepatectomy
title Dealing with an insufficient future liver remnant: Portal vein embolization and two‐stage hepatectomy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T03%3A16%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dealing%20with%20an%20insufficient%20future%20liver%20remnant:%20Portal%20vein%20embolization%20and%20two%E2%80%90stage%20hepatectomy&rft.jtitle=Journal%20of%20surgical%20oncology&rft.au=Kawaguchi,%20Yoshikuni&rft.date=2019-04-01&rft.volume=119&rft.issue=5&rft.spage=594&rft.epage=603&rft.pages=594-603&rft.issn=0022-4790&rft.eissn=1096-9098&rft_id=info:doi/10.1002/jso.25430&rft_dat=%3Cproquest_cross%3E2193305115%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3880-6bf5d1244186ecd01a5cef09a8aed7e6e8f94c28aefd2eb88df617d09ce09e243%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2193305115&rft_id=info:pmid/30825223&rfr_iscdi=true